Cargando…
The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
BACKGROUND: Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable. Due to the various negative health effects of smoking, nicotine dependence contributes to the high mortality in this patient group. The purpose of t...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276187/ https://www.ncbi.nlm.nih.gov/pubmed/18348722 http://dx.doi.org/10.1186/1477-7517-5-10 |
_version_ | 1782151973862113280 |
---|---|
author | Wapf, Victoria Schaub, Michael Klaeusler, Beat Boesch, Lukas Stohler, Rudolf Eich, Dominique |
author_facet | Wapf, Victoria Schaub, Michael Klaeusler, Beat Boesch, Lukas Stohler, Rudolf Eich, Dominique |
author_sort | Wapf, Victoria |
collection | PubMed |
description | BACKGROUND: Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable. Due to the various negative health effects of smoking, nicotine dependence contributes to the high mortality in this patient group. The purpose of the current study was to investigate Swiss methadone and buprenorphine-maintained patients' willingness to stop smoking and to clarify further smoking cessation procedures. METHODS: Substance abuse history, nicotine dependence, and readiness to stop smoking were assessed in a sample of 103 opiate-dependent patients in the metropolitan area of Zurich, Switzerland. Patients were asked to document their smoking patterns and readiness to quit. RESULTS: Only a small number of patients were willing to quit smoking cigarettes (10.7%) and, even though bupropione or nicotine replacement therapy was included in the fixed daily treatment care, only one patient received nicotine replacement therapy for smoking cessation. A diagnosis of depression in patients' clinical records was associated with readiness to stop smoking. No significant associations were found between readiness to quit smoking and age, methadone treatment characteristics, and presence of co-dependencies. CONCLUSION: The current prescription level of best medicine for nicotine dependence in Swiss methadone and buprenorphine-maintained patients is far from adequate. Possible explanations and treatment-relevant implications are discussed. |
format | Text |
id | pubmed-2276187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22761872008-03-28 The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients Wapf, Victoria Schaub, Michael Klaeusler, Beat Boesch, Lukas Stohler, Rudolf Eich, Dominique Harm Reduct J Research BACKGROUND: Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable. Due to the various negative health effects of smoking, nicotine dependence contributes to the high mortality in this patient group. The purpose of the current study was to investigate Swiss methadone and buprenorphine-maintained patients' willingness to stop smoking and to clarify further smoking cessation procedures. METHODS: Substance abuse history, nicotine dependence, and readiness to stop smoking were assessed in a sample of 103 opiate-dependent patients in the metropolitan area of Zurich, Switzerland. Patients were asked to document their smoking patterns and readiness to quit. RESULTS: Only a small number of patients were willing to quit smoking cigarettes (10.7%) and, even though bupropione or nicotine replacement therapy was included in the fixed daily treatment care, only one patient received nicotine replacement therapy for smoking cessation. A diagnosis of depression in patients' clinical records was associated with readiness to stop smoking. No significant associations were found between readiness to quit smoking and age, methadone treatment characteristics, and presence of co-dependencies. CONCLUSION: The current prescription level of best medicine for nicotine dependence in Swiss methadone and buprenorphine-maintained patients is far from adequate. Possible explanations and treatment-relevant implications are discussed. BioMed Central 2008-03-18 /pmc/articles/PMC2276187/ /pubmed/18348722 http://dx.doi.org/10.1186/1477-7517-5-10 Text en Copyright © 2008 Wapf et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wapf, Victoria Schaub, Michael Klaeusler, Beat Boesch, Lukas Stohler, Rudolf Eich, Dominique The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients |
title | The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients |
title_full | The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients |
title_fullStr | The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients |
title_full_unstemmed | The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients |
title_short | The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients |
title_sort | barriers to smoking cessation in swiss methadone and buprenorphine-maintained patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276187/ https://www.ncbi.nlm.nih.gov/pubmed/18348722 http://dx.doi.org/10.1186/1477-7517-5-10 |
work_keys_str_mv | AT wapfvictoria thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT schaubmichael thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT klaeuslerbeat thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT boeschlukas thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT stohlerrudolf thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT eichdominique thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT wapfvictoria barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT schaubmichael barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT klaeuslerbeat barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT boeschlukas barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT stohlerrudolf barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients AT eichdominique barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients |